Hostname: page-component-77c89778f8-n9wrp Total loading time: 0 Render date: 2024-07-18T01:10:29.794Z Has data issue: false hasContentIssue false

Use of potassium titanyl phosphate (KTP) laser Dermastat in the treatment of recurrent anterior epistaxis – a new technique

Published online by Cambridge University Press:  08 August 2016

A Jain*
Affiliation:
Department of Otolaryngology, Royal Free London NHS Foundation Trust, UK
S J Frampton
Affiliation:
Department of Otolaryngology, Poole Hospital NHS Foundation Trust, UK
R Sachidananda
Affiliation:
Department of Otolaryngology, People Tree Hospitals and Manipal Northside Hospital, Bengaluru, India
P K Jain
Affiliation:
Department of Otolaryngology, Poole Hospital NHS Foundation Trust, UK
*
Address for correspondence: Dr Abhiney Jain, Department of Otolaryngology, Royal Free London NHS Foundation Trust, Pond Street, London, UK E-mail: abhiney.jain@nhs.net

Abstract

Objective:

To evaluate the short- to medium-term effectiveness of potassium titanyl phosphate (KTP) laser Dermastat in patients with recurrent anterior epistaxis.

Method:

Fifty-eight patients presenting with recurrent anterior epistaxis were treated using potassium titanyl phosphate laser Dermastat. Those with recurrent epistaxis arising from prominent vessels in Little's area, and/or those for whom treatment with silver nitrate cautery failed, were included. The main outcome measure was resolution of epistaxis at two months.

Results:

Fifty-eight patients were treated; 27 were under 18 years old. Thirty patients had prominent vessels. Thirty-one patients had undergone previous cautery treatment. Thirty-eight patients had treatment to the left side, 19 to the right and 1 to both. At two months, 74 per cent reported resolution of epistaxis with no complications. This increased to 78 per cent at further follow up.

Conclusion:

Our technique is a successful, safe treatment for recurrent anterior epistaxis in an otherwise treatment-resistant group. A single procedure is effective. The handpiece and tip are reusable and sterilisable, resulting in cost-effectiveness.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Petruson, B, Rudin, R. The frequency of epistaxis in a male population sample. Rhinology 1975;13:129–33Google Scholar
2 Schlosser, RJ. Epistaxis. N Engl J Med 2009;360:784–9Google Scholar
3 Benninger, MS, Marple, BF. Minor recurrent epistaxis: prevalence and a new method for management. Otolaryngol Head Neck Surg 2004;131:317–20Google Scholar
4 Burton, MJ, Doree, CJ. Interventions for recurrent idiopathic epistaxis (nosebleeds) in children. Cochrane Database Syst Rev 2004;(1):CD004461Google Scholar
5 Pope, LE, Hobbs, CG. Epistaxis: an update on current management. Postgrad Med J 2005;81:309–14Google Scholar
6 Chiu, T, Dunn, JS. An anatomical study of the arteries of the anterior nasal septum. Otolaryngol Head Neck Surg 2006;134:33–6Google Scholar
7 Pinto, J, Jeswani, S. Rhinitis in the geriatric population. Allergy Asthma Clin Immunol 2010;6:10 Google Scholar
8 Calder, N, Kang, S, Fraser, L, Kunanandam, T, Montgomery, J, Kubba, H. A double-blind randomized controlled trial of management of recurrent nosebleeds in children. Otolaryngol Head Neck Surg 2009;140:670–4Google Scholar
9 Murthy, P, Laing, MR. An unusual, severe adverse reaction to silver nitrate cautery for epistaxis in an immunocompromised patient. Rhinology 1996;34:186–7Google Scholar
10 Robertson, S, Kubba, H. Long-term effectiveness of antiseptic cream for recurrent epistaxis in childhood: five-year follow up of a randomised, controlled trial. J Laryngol Otol 2008;122:1084–7Google Scholar
11 Kodama, S, Yoshida, K, Nomi, N, Fujita, K, Suzuki, M. Successful treatment of nasal septum hemangioma with the Harmonic Scalpel: a case report. Auris Nasus Larynx 2006;33:475–8Google Scholar
12 Ruddy, J, Proops, DW, Pearman, K, Ruddy, H. Management of epistaxis in children. Int J Pediatr Otorhinolaryngol 1991;21:139–42Google Scholar
13 Harvey, RJ, Kanagalingam, J, Lund, VJ. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis. Am J Rhinol 2008;22:182–7Google Scholar
14 Werner, A, Baumler, W, Zietz, S, Kuhnel, T, Hohenleutner, U, Landthaler, M. Hereditary haemorrhagic telangiectasia treated by pulsed neodymium:yttrium-aluminium-garnet (Nd:YAG) laser (1,064 nm). Lasers Med Sci 2008;23:385–91Google Scholar
15 Clark, C, Cameron, H, Moseley, H, Ferguson, J, Ibbotson, SH. Treatment of superficial cutaneous vascular lesions: experience with the KTP 532 nm laser. Lasers Med Sci 2004;19:15 CrossRefGoogle ScholarPubMed
16 Gossner, L, May, A, Stolte, M, Seitz, G, Hahn, EG, Ell, C. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc 1999;49:812 Google Scholar
17 Radosevich, JA, ed. Head & Neck Cancer: Current Perspectives, Advances, and Challenges. Dordrecht: Springer, 2013;631–3Google Scholar
18 Yan, Y, Olszewski, A, Hoffman, M, Zhuang, P, Ford, C, Dailey, S et al. Use of lasers in laryngeal surgery. J Voice 2010;24:102–9CrossRefGoogle ScholarPubMed